GENE ONLINE|News &
Opinion
Blog

Joy Lin

Without knowledge, there is no imagination. Without imagination, knowledge is meaningless

WRITTEN BY Joy Lin

ImmunoGen Wins FDA Accelerated Approval For Ovarian Cancer Drug
2022-11-16
Roche’s Gantenerumab Fails Trials In Alzheimer’s Disease
2022-11-15
Indivior Buys Opiant For $145 Million, Adds Opioid Overdose Treatments To Portfolio
2022-11-15
Moderna To Collaborate With Harbour BioMed On Nucleic Acid-Based Cancer Therapies
2022-11-14
CDC Warns Of “Tripledemic” Winter Amid Rising Flu And RSV Cases
2022-11-14
FDA Rejects BrainStorm Cell Therapeutics’ BLA For ALS Drug
2022-11-11
Zenas Picks Up $118 Million To Advance Phase 3 For Autoimmune Candidate
2022-11-10
Cyagen, Neurophth Ink $140 Million Deal For AI-Designed AAV Capsids
2022-11-08
CSL Promises $4 Billion In Biobucks For Arcturus’ Self-Amplifying mRNA Vaccines
2022-11-03
Exelixis, Cybrexa Pen $700 Million Deal Over Peptide-Drug Conjugate
2022-11-02
Santhera, ReveraGen’s Duchenne Drug Accepted By EMA While Anticipating FDA Priority Review
2022-11-01
Thermo Fisher Announces $59 Million Lab Expansion In Kentucky, Reveals AI Deal With Genoox
2022-10-28
Gilead Touts Long-Term Efficacy And Safety Data For HIV Drug
2022-10-26
Astellas Invests $50 Million In Taysha, Licenses Two CNS Gene Therapies
2022-10-25
Eisai Touts Lenvima Efficacy In Thyroid Cancer Study
2022-10-24
1 5 6 7 8 9 25
Scroll to Top